The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Month: April 2020

Microbiome after coronavirus: Investing in the power of microbes
Editor's Choice

Microbiome after coronavirus: Investing in the power of microbes

APR 30, 2020
Until next Probiota, savor the learnings of Probiota Dublin 2020
Editor's Choice

Until next Probiota, savor the learnings of Probiota Dublin 2020

APR 30, 2020
Validity Attack on US Patent for Bifidobacetrium Combo-Therapy: What can we learn?
Editor's Choice

Validity Attack on US Patent for Bifidobacetrium Combo-Therapy: What can we learn?

APR 29, 2020
Chr. Hansen acquires HSO Health Care to grow probiotics offering for women’s health
Biotics and Supplements

Chr. Hansen acquires HSO Health Care to grow probiotics offering for women’s health

APR 23, 2020
The Lactobacillus taxonomy change has arrived! What do you need to know?
Editor's Choice

The Lactobacillus taxonomy change has arrived! What do you need to know?

APR 21, 2020
Quadram Institute part of consortium using new vaccine delivery systems & synthetic biology to tackle coronavirus
GMO & Synbio

Quadram Institute part of consortium using new vaccine delivery systems & synthetic biology to tackle coronavirus

APR 10, 2020
Lodo Therapeutics Achieves Preclinical Milestone In Strategic Collaboration with Genentech
Finance

Lodo Therapeutics Achieves Preclinical Milestone In Strategic Collaboration with Genentech

APR 9, 2020
OxThera announces completion of recruitment in Phase 3 ePHex study with Oxabact® in patients with primary hyperoxaluria
Clinical & Manufacturing

OxThera announces completion of recruitment in Phase 3 ePHex study with Oxabact® in patients with primary hyperoxaluria

APR 8, 2020
Gilead Sciences & Second Genome Announce Strategic Collaboration in Biomarker and IBD Drug Discovery
Finance

Gilead Sciences & Second Genome Announce Strategic Collaboration in Biomarker and IBD Drug Discovery

APR 7, 2020
Microbiome search engine can increase efficiency in disease detection and diagnosis
Pharma & Human Health

Microbiome search engine can increase efficiency in disease detection and diagnosis

APR 7, 2020
A common gut microbe secretes a carcinogen
Editor's Choice

A common gut microbe secretes a carcinogen

APR 4, 2020